Taguchi Y-H, Turki Turki
Department of PhysicsChuo University Tokyo 112-8551 Japan.
Department of Computer ScienceKing Abdulaziz University Jeddah 21589 Saudi Arabia.
IEEE J Sel Top Signal Process. 2021 Feb 23;15(3):746-758. doi: 10.1109/JSTSP.2021.3061251. eCollection 2021 Apr.
To better understand the genes with altered expression caused by infection with the novel coronavirus strain SARS-CoV-2 causing COVID-19 infectious disease, a tensor decomposition (TD)-based unsupervised feature extraction (FE) approach was applied to a gene expression profile dataset of the mouse liver and spleen with experimental infection of mouse hepatitis virus, which is regarded as a suitable model of human coronavirus infection. TD-based unsupervised FE selected 134 altered genes, which were enriched in protein-protein interactions with orf1ab, polyprotein, and 3C-like protease that are well known to play critical roles in coronavirus infection, suggesting that these 134 genes can represent the coronavirus infectious process. We then selected compounds targeting the expression of the 134 selected genes based on a public domain database. The identified drug compounds were mainly related to known antiviral drugs, several of which were also included in those previously screened with an method to identify candidate drugs for treating COVID-19.
为了更好地了解由导致COVID-19传染病的新型冠状病毒SARS-CoV-2感染引起的表达改变的基因,一种基于张量分解(TD)的无监督特征提取(FE)方法被应用于小鼠肝炎病毒实验感染的小鼠肝脏和脾脏的基因表达谱数据集,小鼠肝炎病毒被视为人类冠状病毒感染的合适模型。基于TD的无监督FE选择了134个表达改变的基因,这些基因在与orf1ab、多蛋白和3C样蛋白酶的蛋白质-蛋白质相互作用中富集,众所周知,这些蛋白在冠状病毒感染中起关键作用,这表明这134个基因可以代表冠状病毒感染过程。然后,我们基于公共领域数据库选择了针对这134个选定基因表达的化合物。鉴定出的药物化合物主要与已知的抗病毒药物有关,其中几种也包含在先前用一种方法筛选出的用于治疗COVID-19的候选药物中。